Home | Welcome to Contract Pharma   
Last Updated Saturday, April 25 2015

Print

Topics - Business Trends


Refine by Date:
From: To:
Published March 17, 2015
Commercial launch expands Endo's growing branded pharmaceutical men's health portfolio Read More »
Published March 17, 2015
First Taiwanese pharma firm to directly sell generics under its own label in U.S. Read More »
Published March 13, 2015
Move will create 100 new jobs, capital investment of more than $9 million Read More »
Published March 13, 2015
$15 million project calls for new 75,000-square-foot facility on Long Island. Read More »
Published March 11, 2015
Will lead Fosfestrol product initiatives Read More »
Published February 27, 2015
Will offer production of API using microbial expression systems Read More »
Published February 27, 2015
Goal is to identify best-in-class RORγ inhibitors to treat autoimmune disease Read More »
Published February 27, 2015
Shifts production in-house after US FDA concerns about CMO Emcure Read More »
Published February 27, 2015
New drug company launched by former CEO of Retrophin Read More »
Published January 30, 2015
Continuous manufacturing and QbD expand, supply chain concerns persist Read More »
Published January 30, 2015
MS portfolio drives growth Read More »
Published January 30, 2015
U.S. patent expirations hurt results Read More »
By Dr. Gurpreet Sandhu, Reva Pharmachem
Published January 29, 2015
The healthcare market in Vietnam is an attractive destination for investment. Read More »
By S. Harachand, Contributing Editor
Published January 29, 2015
Can it snip contested clauses? Read More »
By Chad Moore, Robert W. Baird & Co. Inc.
Published January 29, 2015
Last year was hot, but 2015 looks to be hotter. Read More »


Receive free Contract Pharma Direct emails
Sign up now to receive the weekly newsletter, and more!

Enter your email address:
Follow Contract Pharma On